AHA, Health Organizations Express Support for S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act

AHA, health organizations letter to Senate Chairman, Lamar Alexander and Ranking Member Patty Murray, expressing support of S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act which is a holistic and sustainable approach to eliminating drugs shortages and addressing vulnerabilities in the drug supply chain.

Related Resources

Letter/Comment
Public
 AHA, health organizations letter to Representatives Peters, Engel, Eshoo, Schrader, Guthrie, Hudson, McCaul, and Bilirakis, supporting the…
Letter/Comment
Public
AHA, others urge Senate HELP Committee to advance MEDS Act (S.2723).
Letter/Comment
Public
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe…
Letter/Comment
Public
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.  Although…
Letter/Comment
Public
The AHA appreciates the opportunity to comment on the Drug Enforcement Administration’s proposed notice on aggregate production quotas for schedule I and II…
Letter/Comment
Public
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and…